Clinical Trial Update: An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis C

View source ↗

Summary

This clinical trial update documents the completed observational study evaluating Pegasys in dual- or triple-therapy regimens for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C, Chronic | Status: COMPLETED